$1.16
-0.16-11.83%
At close: -
$1.16
0.00500.43%
After Hours: 4:58 PM EDT
15 minutes delayed
Processa Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Processa Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $-1.01 | $-0.98 | -3.06 % |
Dec 2023 | 2024-03-29 | $-1.68 | $-1.60 | -5.00 % |
Mar 2023 | 2023-05-15 | $-3.60 | $-5.60 | 35.7 % |
Dec 2022 | 2023-03-30 | $-16.00 | $-6.40 | -150.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Processa Pharma (PCSA) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
The Actual EPS was $-1.01, which missed the estimate of $-0.98.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.